Gut Transit Is Associated With Gastrointestinal Symptoms and Gut Hormone Profile in Patients With Cirrhosis  Evangelos Kalaitzakis, Riadh Sadik, Jens.

Slides:



Advertisements
Similar presentations
Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants  Jacqueline G. O'Leary, Carmen Landaverde,
Advertisements

The Role of Psychosocial Care in Adapting to Health Care Reform
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Glomus Tumor of the Stomach—A Tumor That Needs to Be Differentiated From Gastrointestinal Stromal Tumor  Shuisheng Zhang, Jianwei Zhang, Chengfeng Wang 
Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.
Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome  Yehuda Ringel, Rachel E. Williams, Linda Kalilani,
Alan N. Desmond, Sebastian McWilliams, Michael M
Issue Highlights Clinical Gastroenterology and Hepatology
A Rare Cause of Life-Threatening Upper Gastrointestinal Bleeding
Coordinating Care in Patients With Cirrhosis
Shou–Jiang Tang, Feriyl Bhaijee 
Celiac Disease and Persistent Symptoms
A Shocking Cystory Clinical Gastroenterology and Hepatology
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Factors Related to Fatigue in Patients With Cirrhosis Before and After Liver Transplantation  Evangelos Kalaitzakis, Axel Josefsson, Maria Castedal, Pia.
Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study  Harry Wu, Geoffrey C. Nguyen  Clinical.
Prevalence and Mechanisms of Malnutrition in Patients With Advanced Liver Disease, and Nutrition Management Strategies  Kally Cheung, Samuel S. Lee, Maitreyi.
Phillip S. Ge, MD, Bruce A. Runyon, MD 
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Georg Elias, Nabil Toubia  Clinical Gastroenterology and Hepatology 
Should the Reflex Be Reflux
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Jessica L. Mellinger, Michael L. Volk 
Issue Highlights Clinical Gastroenterology and Hepatology
Translating Improved Quality of Care Into an Improved Quality of Life for Patients With Inflammatory Bowel Disease  Corey A. Siegel, John I. Allen, Gil.
Atopic Characteristics of Adult Patients With Eosinophilic Esophagitis
Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay?  Brian J. McMahon, MD, Brenna C. Simons, PhD  Clinical.
The Ghrelin Agonist RM-131 Accelerates Gastric Emptying of Solids and Reduces Symptoms in Patients With Type 1 Diabetes Mellitus  Andrea Shin, Michael.
Endoscopic Therapy for Barrett's Esophagus
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
Kasaya Tantiphlachiva, Priyanka Rao, Ashok Attaluri, Satish S.C. Rao 
Metastatic Malignant Melanoma of the Gastrointestinal Tract
Abnormal Liver Tests and Fatty Liver on Ultrasound
Gastroenterology in a New Era of Accountability: Part 2
Reduced Hospitalization Cost for Upper Gastrointestinal Events That Occur Among Elderly Veterans Who Are Gastroprotected  Neena S. Abraham, Christine.
New Models of Gastroenterology Practice
Issue Highlights Clinical Gastroenterology and Hepatology
Kaposi’s Sarcoma Involving the Gastrointestinal Tract
David H. Bruining, William J. Sandborn 
Eric S. Orman, Marwan Ghabril, Naga Chalasani 
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Patient-Reported Outcomes of Cirrhosis
A Young Woman With Gallstone Pancreatitis and Abnormal Liver Tests: When Is Endoscopic Retrograde Cholangiopancreatography Needed?  Andrew D. Rhim, Michael.
Lia C. Kaufman, Jana G. Hashash 
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Alan Bonder, MD, Nezam H. Afdhal, MD 
No Benefit From Platelet Transfusion for Gastrointestinal Bleeding in Patients Taking Antiplatelet Agents  Liam Zakko, Tarun Rustagi, Maura Douglas, Loren.
Thrombocytopenia With Abnormal Liver Function Tests
Immune Dysfunction and Infections in Patients With Cirrhosis
Gastrointestinal Tuberculosis: An Unusual Presentation
Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders  Evan S. Dellon, MD,
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Patrick Yachimski, William P. Puricelli, Norman S. Nishioka 
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Hairball in the Stomach: A Case of Gastric Trichobezoar
Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants  Jacqueline G. O'Leary, Carmen Landaverde,
Black and White Liver Clinical Gastroenterology and Hepatology
Rintaro Hashimoto, Akimichi Chonan 
Adverse Outcomes: Why Bad Things Happen to Good People
Issue Highlights Clinical Gastroenterology and Hepatology
M. Babitha Reddy, David M. Poppers, Cora Uram–Tuculescu 
Sanjay K. Murthy, E. Jenny Heathcote, Geoffrey C. Nguyen 
Rintaro Hashimoto, Akimichi Chonan 
The Role of Psychosocial Care in Adapting to Health Care Reform
The Stomach in Diabetes: From Villain to Ally
Metastatic Malignant Melanoma of the Gastrointestinal Tract
Karanprit Singh, Prateek Chapalamadugu, Peter Malet 
Choosing Wisely and the Perceived Drivers of Endoscopy Use
Presentation transcript:

Gut Transit Is Associated With Gastrointestinal Symptoms and Gut Hormone Profile in Patients With Cirrhosis  Evangelos Kalaitzakis, Riadh Sadik, Jens Juul Holst, Lena Öhman, Einar Björnsson  Clinical Gastroenterology and Hepatology  Volume 7, Issue 3, Pages 346-352 (March 2009) DOI: 10.1016/j.cgh.2008.11.022 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Frequency of transit abnormalities in patients with liver cirrhosis (black bars, n = 42) and healthy controls (white bars, n = 83). Reference values were based on percentiles 10 and 90 of the transit values of the healthy controls (n = 83).27,29 *P < .05; **P < .005. Clinical Gastroenterology and Hepatology 2009 7, 346-352DOI: (10.1016/j.cgh.2008.11.022) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Median (half IQR) postprandial (A) glucose, (B) insulin, (C) leptin, and (D) ghrelin profiles in patients with cirrhosis (solid line, n = 25) and healthy controls (dashed line, n = 10). In multivariate repeated-measures analysis of variance, the effect of group was significant (P < .05) for glucose, insulin, and ghrelin. The effect of time was significant (P < .05) for glucose, insulin, and leptin, and the effect of group-time interaction was significant (P < .05) for glucose. Analysis of leptin data as the ratio leptin/BMI yielded similar results. *P < .05, **P < .005 between patients with cirrhosis and healthy controls. Clinical Gastroenterology and Hepatology 2009 7, 346-352DOI: (10.1016/j.cgh.2008.11.022) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 Median (half IQR) postprandial (A) GLP-1 and (B) PYY levels in patients with cirrhosis (solid line, n = 25) and healthy controls (dashed line, n = 10). In multivariate repeated-measures analysis of variance, the effect of time was significant (P < .05) for GLP-1 and PYY. The effect of group-time interaction was significant (P < .05) for GLP-1 only. *P < .05, **P < .005 between patients with cirrhosis and healthy controls. Clinical Gastroenterology and Hepatology 2009 7, 346-352DOI: (10.1016/j.cgh.2008.11.022) Copyright © 2009 AGA Institute Terms and Conditions